个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Safety and outcomes by disease etiology in sorafenib-treated uHCC patients in clinical practice: final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib)

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Sanyal, Arun J.[1] * ; Lencioni, Riccardo[2,3] ; Ye, Sheng-Long[4,5] ; Kudo, Masatoshi[6] ; Venook, Alan[7] ; Bronowicki, Jean-Pierre[8] ; Chen, Xiao-Ping[9] ; Dagher, Lucy[10] ; Furuse, Junji[11] ; Geschwind, Jean-Francois H.[12] ; Ladron de Guevara, Laura[13] ; Papandreou, Christos[14] ; Takayama, Tadatoshi[15] ; Yoon, Seung Kew[16] ; Nakajima, Keiko[17] ; Marrero, Jorge A.[18] ;
单位： [1]Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA [2]Pisa Univ Hosp, Div Diagnost Imaging & Intervent, Pisa, Italy [3]Univ Pisa, Sch Med, I-56100 Pisa, Italy [4]Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China [5]Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China [6]Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan [7]Univ Calif San Francisco, San Francisco, CA 94143 USA [8]Univ Lorraine, Dept Gastroenterol & Hepatol, INSERM, U954,Univ Hosp, Nancy, France [9]Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China [10]Policlin Metropolitana, Caracas, Venezuela [11]Kyorin Univ, Sch Med, Tokyo, Japan [12]Johns Hopkins Univ, Sch Med, Baltimore, MD USA [13]Hosp Angeles Clin Londres, Mexico City, DF, Mexico [14]Univ Hosp Larissa, Larisa, Greece [15]Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan [16]Catholic Univ Korea, Seoul, South Korea [17]Bayer HealthCare Pharmaceut, Global Med Affairs, Montville, NJ USA [18]Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2012]版：
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
JCR分区：
出版当年[2011]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者：
第一作者单位： [1]Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA
推荐引用方式(GB/T 7714)：
Sanyal Arun J.,Lencioni Riccardo,Ye Sheng-Long,et al.Safety and outcomes by disease etiology in sorafenib-treated uHCC patients in clinical practice: final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib)[J].HEPATOLOGY.2013,58:1261A-1261A.
APA：
Sanyal, Arun J.,Lencioni, Riccardo,Ye, Sheng-Long,Kudo, Masatoshi,Venook, Alan...&Marrero, Jorge A..(2013).Safety and outcomes by disease etiology in sorafenib-treated uHCC patients in clinical practice: final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib).HEPATOLOGY,58,
MLA：
Sanyal, Arun J.,et al."Safety and outcomes by disease etiology in sorafenib-treated uHCC patients in clinical practice: final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib)".HEPATOLOGY 58.(2013):1261A-1261A

资源点击量：589 今日访问量：0 总访问量：441 更新日期：2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）